TUBB4A Interacts with MYH9 to Protect the Nucleus during Cell Migration and Promotes Prostate Cancer via GSK3β/β-Catenin Signaling

Researchers suggested an oncogenic role of tubulin beta class IVa (TUBB4A) and provided a potentially actionable therapeutic target for prostate cancers with TUBB4A overexpression.